NorthWest Biotherapeutics Inc (NWBO)

[NRF]

At the rate they've been increasing the size of the booth and the price of said booth as a result, they will surpass all the BPs by next ASCO.

This would be a ludicrous thing to do for a company with a failed trial, who is looking to delay for ATLEAST another 5 years.

As a biotech that is nowhere on the scale and level of the complexity of most BPs, I doubt we will actually see much of an increase in booth size by 2023 ASCO.

My point is they're getting a big booth because they have imminent news to share, and expect enough interest to need one of the biggest booths at the conference. You'd be silly to think that NWBO has a mission to waste 400k+ year after year just so they can feel like they're playing at the big boys table...